Based in Taiwan, ASCENDO Biotechnology is a startup.
ASCENDO Biotechnology is a clinical-stage biopharmaceutical company developing immunotherapies that target the innate immune system, focusing on the TLT-1/CD11b checkpoint pathway to treat solid tumors and autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.